← Leaderboards
Stephen F Vatner
Univ Of Med/Dent Of Nj-Nj Medical School
$47,746,285
Attributed
$49,067,270
Total exposure
23
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.1M · FY2005–23$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$61,479,450 · 24
By mechanism
P01$27,238,225 · 7
R01$27,221,233 · 10
T32$2,916,609 · 1
P20$1,558,222 · 1
R37$1,199,288 · 1
S10$661,993 · 2
Top collaborators
- Dorothy E Vatner4 shared
- M. Maral Mouradian1 shared
Most similar at Univ Of Med/Dent Of Nj-Nj Medical School
Same institution · by research overlap
- Bin Tian$12,568,175
- Joshua R Berlin$3,020,092
Others in their field
Top investigators on “Heart Failure”
- Judith S Hochman · New York University School Of Medicine$120,321,606
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Walter N Kernan · Yale University$42,197,025
- Dalane W Kitzman · Wake Forest University$40,701,149
- David Couper · Univ Of North Carolina Chapel Hill$37,959,091
Research focus
Heart FailureChronicMolecularAgingMediatingKnock-OutCardiacLongevityProteomicsKnockout MicePathway InteractionsBaseMyocardial IschemiaHeartOxidative StressHeart DiseasesGenomicsApoptosisSignal TransductionSignal PathwayGrantBlood FlowMouse ModelMyocardial
Grant awards (102)
A Novel Pharmacological Inhibitor of Adenylyl Cyclase Type 5 to Treat Alzheimer's Disease$252,130
R41 · FY2023 · AG · contact PI
Alzheimerâs Disease Protection by Reduced Adenylyl Cyclase Type 5$431,750
R21 · FY2022 · AG · contact PI
Angiogenesis Protection Induced by sFRP3 Myocyte/Vascular Cross-Talk$564,480
R01 · FY2020 · HL
Skeletal Muscle and Brown Adipose Mechanisms Mediating Cardiovascular Risk Factor Protection in RGS14 KO$534,250
R01 · FY2020 · HL · contact PI
Angiogenesis Protection Induced by sFRP3 Myocyte/Vascular Cross-Talk$548,580
R01 · FY2019 · HL
Skeletal Muscle and Brown Adipose Mechanisms Mediating Cardiovascular Risk Factor Protection in RGS14 KO$534,250
R01 · FY2019 · HL · contact PI
Skeletal Muscle Basis for Improved Exercise Endurance in RGS14 KO$500,837
R01 · FY2019 · HL · contact PI
Vascular Protection in Hibernating Woodchucks$454,738
R01 · FY2019 · HL · contact PI
RGS 14 Disruption, Vascular Effects Leading to Cardioprotection$550,023
R01 · FY2018 · HL · contact PI
Angiogenesis Protection Induced by sFRP3 Myocyte/Vascular Cross-Talk$548,580
R01 · FY2018 · HL
Skeletal Muscle and Brown Adipose Mechanisms Mediating Cardiovascular Risk Factor Protection in RGS14 KO$534,250
R01 · FY2018 · HL · contact PI
Skeletal Muscle Basis for Improved Exercise Endurance in RGS14 KO$500,837
R01 · FY2018 · HL · contact PI
Vevo 3100 High Resolution Imaging System$459,393
S10 · FY2018 · OD · contact PI
Vascular Protection in Hibernating Woodchucks$452,738
R01 · FY2018 · HL · contact PI
RGS 14 Disruption, Vascular Effects Leading to Cardioprotection$564,862
R01 · FY2017 · HL · contact PI
Angiogenesis Protection Induced by sFRP3 Myocyte/Vascular Cross-Talk$548,580
R01 · FY2017 · HL
Skeletal Muscle and Brown Adipose Mechanisms Mediating Cardiovascular Risk Factor Protection in RGS14 KO$534,250
R01 · FY2017 · HL · contact PI
Skeletal Muscle Basis for Improved Exercise Endurance in RGS14 KO$500,837
R01 · FY2017 · HL · contact PI
Vascular Protection in Hibernating Woodchucks$452,738
R01 · FY2017 · HL · contact PI
RGS 14 Disruption, Vascular Effects Leading to Cardioprotection$619,188
R01 · FY2016 · HL · contact PI
Skeletal Muscle Basis for Improved Exercise Endurance in RGS14 KO$500,837
R01 · FY2016 · HL · contact PI
Intrinsic Vascular Smooth Muscle Cell Stiffness$497,378
R01 · FY2016 · HL · contact PI
Vascular Protection in Hibernating Woodchucks$454,738
R01 · FY2016 · HL · contact PI
RGS 14 Disruption, Vascular Effects Leading to Cardioprotection$629,383
R01 · FY2015 · HL · contact PI
Intrinsic Vascular Smooth Muscle Cell Stiffness$489,917
R01 · FY2015 · HL · contact PI
RGS 14 Disruption, Vascular Effects Leading to Cardioprotection$51,941
R01 · FY2015 · HL · contact PI
Intrinsic Vascular Smooth Muscle Cell Stiffness$487,429
R01 · FY2014 · HL · contact PI
Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO$448,783
R01 · FY2014 · HL · contact PI
Intrinsic Vascular Smooth Muscle Cell Stiffness$79,500
R01 · FY2014 · HL · contact PI
Adenylyl cyclase isoforms in hypertrophy and heart failure$447,098
R01 · FY2013 · HL · contact PI
Intrinsic Vascular Smooth Muscle Cell Stiffness$442,167
R01 · FY2013 · HL · contact PI
Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO$430,225
R01 · FY2013 · HL · contact PI
Integrative Mechanisms in Cardiovascular Disease$196,004
T32 · FY2013 · HL · contact PI
Longevity and Stress Resistance$69,793
P01 · FY2013 · AG · contact PI
Adenylyl cyclase isoforms in hypertrophy and heart failure$469,235
R01 · FY2012 · HL · contact PI
Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO$453,345
R01 · FY2012 · HL · contact PI
Integrative mechanisms in Cardiovascular Disease$209,834
T32 · FY2012 · HL · contact PI
Longevity and Stress Resistance$1,457,778
P01 · FY2011 · AG · contact PI
AC5 Inhibitor Treatment for Heart Failure$779,111
P20 · FY2011 · HL · contact PI
Cardiovascular Control in Normal and Disease States$729,851
R01 · FY2011 · HL · contact PI
Longevity and Stress Resistance$579,991
P01 · FY2011 · AG · contact PI
Adenylyl cyclase isoforms in hypertrophy and heart failure$468,924
R01 · FY2011 · HL · contact PI
Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO$468,800
R01 · FY2011 · HL · contact PI
Integrative mechanisms in Cardiovascular Disease$170,402
T32 · FY2011 · HL · contact PI
Longevity and Stress Resistance$2,054,477
P01 · FY2010 · AG · contact PI
AC5 Inhibitor Treatment for Heart Failure$779,111
P20 · FY2010 · HL · contact PI
Cardiovascular Control in Normal and Disease States$737,225
R01 · FY2010 · HL · contact PI
Intrinsic Vascular Smooth Muscle Cell Stiffness$491,296
R01 · FY2010 · HL · contact PI
Adenylyl cyclase isoforms in hypertrophy and heart failure$473,661
R01 · FY2010 · HL · contact PI
Molecular Mechanisms in Chronically Stunned Myocardium$342,976
P01 · FY2010 · HL · contact PI
Integrative mechanisms in Cardiovascular Disease$271,048
T32 · FY2010 · HL · contact PI
Longevity and Stress Resistance$2,182,671
P01 · FY2009 · AG · contact PI
Cardiovascular Control in Normal and Disease States$752,274
R01 · FY2009 · HL · contact PI
Adenylyl cyclase isoforms in hypertrophy and heart failure$467,379
R01 · FY2009 · HL · contact PI
Molecular Mechanisms in Chronically Stunned Myocardium$335,213
P01 · FY2009 · HL · contact PI
Integrative mechanisms in Cardiovascular Disease$268,909
T32 · FY2009 · HL · contact PI
Vevo 770 High Resolution Imaging System$202,600
S10 · FY2009 · RR · contact PI
Longevity and Stress Resistance$1,948,717
P01 · FY2008 · AG · contact PI
Cardiovascular Control in Normal and Disease States$720,993
R01 · FY2008 · HL · contact PI
Molecular Mechanisms in Chronically Stunned Myocardium$321,121
P01 · FY2008 · HL · contact PI
Longevity and Stress Resistance$166,920
P01 · FY2008 · AG · contact PI
Integrative Mechanisms in Cardiovascular Disease$64,202
T32 · FY2008 · HL · contact PI
Myocardial Hypertrophy and Heart Failure$1,915,861
P01 · FY2007 · HL · contact PI
Longevity and Stress Resistance$1,822,342
P01 · FY2007 · AG · contact PI
Aging Effects on Cardiovascular Function$563,924
R01 · FY2007 · AG · contact PI
Integrative Mechanisms in Cardiovascular Disease$524,078
T32 · FY2007 · HL · contact PI
CORE--PATHOLOGY$478,966
P01 · FY2007 · HL · contact PI
Physiology, genomic and proteomic mechanisms in hypertrophy and heart failure$478,965
P01 · FY2007 · HL · contact PI
Molecular Mechanisms in Chronically Stunned Myocardium$330,093
P01 · FY2007 · HL · contact PI
Myocardial Hypertrophy and Heart Failure$1,949,141
P01 · FY2006 · HL · contact PI
Cardiovascular Control in Normal and Disease States$667,364
R01 · FY2006 · HL · contact PI
Aging Effects on Cardiovascular Function$565,797
R01 · FY2006 · AG · contact PI
Integrative Mechanisms in Cardiovascular Disease$524,078
T32 · FY2006 · HL · contact PI
Molecular Mechanisms in Chronically Stunned Myocardium$304,758
P01 · FY2006 · HL · contact PI
CORE--PATHOLOGY$220,513
P01 · FY2006 · HL · contact PI
Physiology, genomic and proteomic mechanisms in hypertrophy and heart failure$220,513
P01 · FY2006 · HL · contact PI
Myocardial Hypertrophy and Heart Failure$1,971,977
P01 · FY2005 · HL
Cardiovascular Control in Normal and Disease States$665,935
R01 · FY2005 · HL
Aging Effects on Cardiovascular Function$564,534
R01 · FY2005 · AG
Integrative Mechanisms in Cardiovascular Disease$458,703
T32 · FY2005 · HL
Mechanisms underlying short term, chronic and true hiber$322,754
P01 · FY2005 · HL
Myocardial Hypertrophy and Heart Failure$1,597,506
P01 · FY2004 · HL
Cardiovascular Control in Normal and Disease States$650,750
R01 · FY2004 · HL
Aging Effects on Cardiovascular Function$549,995
R01 · FY2004 · AG
Integrative Mechanisms in Cardiovascular Disease$229,351
T32 · FY2004 · HL
Myocardial Hypertrophy and Heart Failure$1,451,551
P01 · FY2003 · HL
Cardiovascular Control in Normal and Disease States$635,625
R01 · FY2003 · HL
Aging Effects on Cardiovascular Function$515,362
R01 · FY2003 · AG
Cardiovascular Control in Normal and Disease States$617,111
R01 · FY2002 · HL
Mechanisms underlying short term, chronic and true hiber$296,386
P01 · FY2002 · HL
MYCARDIAL HYPERTOPHY AND HEART FAILURE$1,780,080
P01 · FY2001 · HL
CARDIOVASCULAR CONTROL IN NORMAL AND DISEASE STATES$574,827
R37 · FY2001 · HL
AGING EFFECTS ON CARDIOVASCULAR FUNCTION$360,389
R01 · FY2001 · AG
CORE--MURINE PHYSIOLOGY$220,513
P01 · FY2001 · HL
ADRENERGIC CONTROL IN MECHANISMS IN HYPERTROPHY AND HEART FAILURE$220,513
P01 · FY2001 · HL
Mechanisms underlying short term, chronic and true hiber$0
P01 · FY2001 · HL
MYCARDIAL HYPERTOPHY AND HEART FAILURE$1,746,064
P01 · FY2000 · HL
CARDIOVASCULAR CONTROL IN NORMAL AND DISEASE STATES$624,461
R37 · FY2000 · HL
MYOCARDIAL ISCHEMIA AND CORONARY ARTERY REPERFUSION$375,717
R01 · FY2000 · HL
AGING EFFECTS ON CARDIOVASCULAR FUNCTION$352,333
R01 · FY2000 · AG
CORE--MURINE PHYSIOLOGY$225,036
P01 · FY2000 · HL
ADRENERGIC CONTROL IN MECHANISMS IN HYPERTROPHY AND HEART FAILURE$225,036
P01 · FY2000 · HL